Stem Cell Medicine Ltd.
🇮🇱Israel
- Country
- 🇮🇱Israel
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 11
- Market Cap
- -
Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS
Phase 1
Withdrawn
- Conditions
- Secondary Progressive Multiple Sclerosis (SPMS)
- Interventions
- Biological: SCM-010
- First Posted Date
- 2018-10-04
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Stem Cell Medicine Ltd.
- Registration Number
- NCT03696485
- Locations
- 🇮🇱
Tel Aviv Medical Center, Tel Aviv, Israel
© Copyright 2025. All Rights Reserved by MedPath